4//SEC Filing
Carr Patricia 4
Accession 0001784606-25-000007
CIK 0001232524other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:25 PM ET
Size
10.6 KB
Accession
0001784606-25-000007
Insider Transaction Report
Form 4
Carr Patricia
SVP, Chief Accounting Officer
Transactions
- Sale
Ordinary Shares
2025-12-05$171.11/sh−160$27,378→ 7,012 total - Exercise/Conversion
Ordinary Shares
2025-12-05$140.67/sh+4,500$633,015→ 11,512 total - Sale
Ordinary Shares
2025-12-05$171.20/sh−4,500$770,405→ 7,012 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-12-05−4,500→ 0 totalExercise: $140.67Exp: 2028-02-29→ Ordinary Shares (4,500 underlying)
Footnotes (3)
- [F1]The Reporting Person acquired 160 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025.
- [F2]Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $171.2001 to $171.2601. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- [F3]These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The option fully vested as of March 1, 2022.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001784606
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:25 PM ET
- Size
- 10.6 KB